Temozolomide chronotherapy in patients with glioblastoma: A retrospective single-institute study
Open Access Publication
Rights and Permissions
Anna R Damato, Jingqin Luo, Ruth G N Katumba, Grayson R Talcott, Joshua B Rubin, Erik D Herzog, Jian L Campian, Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study, Neuro-Oncology Advances, Volume 3, Issue 1, January-December 2021, vdab041, https://doi.org/10.1093/noajnl/vdab041. © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact email@example.com.
Damato, Anna R; Luo, Jingqin; Katumba, Ruth G N; Talcott, Grayson R; Rubin, Joshua B; Herzog, Erik D; and Campian, Jian L, "Temozolomide chronotherapy in patients with glioblastoma: A retrospective single-institute study." Neuro-Oncology Advances. 3, 1. vdab041 (2021).
Supplemental material is available for this article at publisher site.